Journals / Experimed / 2023 / Cilt: 13 Sayı: 1

Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages

Journal
Experimed
Pages
15–20
Publication Date
2023-05-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Galectin-3 can play critical functions in the development and progression of endometriosis, so, further studies are needed in this area

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Endometriosis is a gynecological disease associated with chronic pelvic inflammation, pain, and infertility.
📊
Key Findings & Data:Galectin-3 (Gal-3) is a protein that can bind to β-galactosides, which plays an important role in different biological processes according to the stages of the disease in patients with endometriosis.
💡
Conclusion & Impact:Conclusion: Galectin-3 can play critical functions in the development and progression of endometriosis, so, further studies are needed in this area
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Galectin-3 · endometriosis · biomarkers

Abstract

Objective: Endometriosis is a gynecological disease associated with chronic pelvic inflammation, pain, and infertility. Galectin-3 (Gal-3) is a protein that can bind to β-galactosides, which plays an important role in different biological processes according to the stages of the disease in patients with endometriosis. This study aimed to elucidate the importance of Gal-3 in endometriosis, to reveal its potential power as a non-invasive diagnostic biomarker in disease etiopathogenesis. Materials and Methods: The serum concentration of Gal-3 and cancer antigen 125 (CA-125) from whole blood were measured using enzyme-linked immuno sorbent assay (ELISA) and an auto-analyzer, respectively. Gal-3 expression was determined by quantitative real-time polymerase chain reaction (qRT-PCR) from peripheral blood. Results: We found significant differences for Gal-3 expression levels between the endometriosis and control groups (p <0.05). Gal-3 levels in the serum of women with endometriosis are also remarkably increased compared with the control group. Conclusion: Galectin-3 can play critical functions in the development and progression of endometriosis, so, further studies are needed in this area

🔖

Cite This Article

KIZILGEDİK, D. F., CANER, A., YILDIZ, Ç., OKŞAŞOĞLU, B., MISIR, S., YAYLIM, İ., DEMOKAN, S., HEPOKUR, C. (2023). Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages. Experimed, Cilt: 13 Sayı: 1, 15–20. https://ajindex.com/articles/936350

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Bulun SE. Mechanisms of disease endometriosis. N Engl J Med 2009
  2. [CrossRef] google scholar 2. Pabalan N, Jarjanazi H, Christofolini DM, Barbosa CP, Bianco B. Association of the intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms with endometriosis: A systematic review and metaanalysis. Arch Gynecol Obstet 2015
  3. [CrossRef] google scholar 3. Meggyes M, Szereday L, Bohonyi N, Koppan M, Szegedi S, Marics-Kutas A et al. Different expression pattern of TIM-3 and Galectin-9 molecules by peripheral and peritoneal lymphocytes in women with and without endometriosis. Int J Mol Sci 2020
  4. 21(7): 2343. [CrossRef] google scholar 4. Aghajanpour L, Mashayekhi F, Rajaei F. Intercellular adhesion molecule-1 (ICAM-1) gene polymorphism and endometriosis in northern Iran. Arch Gynecol Obstet 2011
  5. [CrossRef] google scholar 5. Caserta D, Di Benedetto L, Bordi G, D’Ambrosio A, Moscarini M. Levels of Galectin-3 and stimulation expressed gene 2 in the peritoneal fluid of women with endometriosis: A pilot study. Gynecol Endocrinol 2014
  6. 30(12): 877-80. [CrossRef] google scholar 6. Sharpe Timms KL. Endometrial anomalies in women with endometriosis. Ann NY Acad Sci 2001
  7. [CrossRef] google scholar 7. Bastón JI, Barañao RI, Ricci AG, Bilotas MA, Olivares CN, Singla JJ. Targeting galectin-1-induced angiogenesis mitigates the severity of endometriosis. J Pathol 2014
  8. 234(3): 329-37. [CrossRef] google scholar 8. Crosignani P, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: An update for clinicians. Hum Reprod Update 2006
  9. [CrossRef] google scholar 9. Heidemann LN, Hartwell D, Heidemann CH, Jochumsen KM. The relation between endometriosis and ovarian cancer - a review. Acta Obstet Gynecol Scand 2014
  10. 93(1): 20. [CrossRef] google scholar 10. Cho S, Mutlu L, Grechukhina O, Taylor HS. Circulating microRNAs as potential biomarkers for endometriosis. Fertil Steril 2015
  11. 103(5): 1252-60. [CrossRef] google scholar 11. Van den Brûle FA, Fernandez PL, Buicu C, Liu FT, Jackers P, Lambotte R, et al. Differential expression of galectin-1 and galectin-3 during first trimester human embryogenesis. Dev Dyn 1997
  12. 399405. [CrossRef] google scholar 12. Fowlis D, Colnot C, Ripoche MA, Poirier F. Galectin-3 is expressed in the notochord, developing bones, and skin of the post implantation mouse embryo. Dev Dyn 1995
  13. 203(2): 241-51. [CrossRef] google scholar 13. Kyama CM, Debrock S, Mwenda JM, D’Hoog